47 related articles for article (PubMed ID: 17431809)
1. Prostate Cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System.
Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Significance of pT3a Lesions as Well as Unilateral Versus Bilateral Invasion Into the Seminal Vesicle in Men With pT3b Prostate Cancer: A Proposal for a New pT3b Subclassification.
Teramoto Y; Numbere N; Wang Y; Miyamoto H
Arch Pathol Lab Med; 2023 Nov; 147(11):1261-1267. PubMed ID: 36656173
[TBL] [Abstract][Full Text] [Related]
3. Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate Cancer.
Schwarz S; Nientiedt C; Prigge ES; Kaczorowski A; Geisler C; Lucena Porcel C; von Knebel Doeberitz M; Hohenfellner M; Duensing S
Pathobiology; 2023; 90(5):312-321. PubMed ID: 37004506
[TBL] [Abstract][Full Text] [Related]
4. Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications.
Potter SR; Epstein JI; Partin AW
Rev Urol; 2000; 2(3):190-5. PubMed ID: 16985773
[TBL] [Abstract][Full Text] [Related]
5. MRI assessment of seminal vesicle involvement by prostate cancer using T2 signal intensity and volume.
Zawaideh JP; Caglic I; Sushentsev N; Priest AN; Warren AY; Carmisciano L; Barrett T
Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38734785
[TBL] [Abstract][Full Text] [Related]
6. Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target.
Ferrari MG; Jimenez-Uribe AP; Wang L; Hoeppner LH; Murugan P; Hahm E; Yu J; Kuzel TM; Gradilone SA; Mansini AP
Oncogene; 2024 Feb; 43(7):484-494. PubMed ID: 38135694
[TBL] [Abstract][Full Text] [Related]
7. Prostate Cancer Local Staging with Magnetic Resonance Imaging.
Lin Y; Johnson LA; Fennessy FM; Turkbey B
Radiol Clin North Am; 2024 Jan; 62(1):93-108. PubMed ID: 37973247
[TBL] [Abstract][Full Text] [Related]
8. Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic target.
Ferrari M; Wang L; Hoeppner L; Hahm E; Yu J; Kuzel T; Mansini A
Res Sq; 2023 Jun; ():. PubMed ID: 37333086
[TBL] [Abstract][Full Text] [Related]
9. Single tertiary cancer center experience on the management of pT3b prostate cancer after robotic-assisted laparoscopic prostatectomy.
Nayak A; El-Taji O; Sukumar S; Piedad J; Ghose A; Hughes R; Alonzi R; Ostler P; Sharma A; Lane T; Adshead J; Vasdev N
Curr Urol; 2022 Dec; 16(4):227-231. PubMed ID: 36714225
[TBL] [Abstract][Full Text] [Related]
10. Predictive model containing PI-RADS v2 score for postoperative seminal vesicle invasion among prostate cancer patients.
Wang H; Ruan M; Wang H; Li X; Hu X; Liu H; Zhou B; Song G
Transl Androl Urol; 2021 Feb; 10(2):584-593. PubMed ID: 33718061
[TBL] [Abstract][Full Text] [Related]
11. Does index tumor predominant location influence prognostic factors in radical prostatectomies?
Billis A; Freitas LLL; Costa LBE; Angelis CM; Carvalho KR; Magna LA; Ferreira U
Int Braz J Urol; 2017; 43(4):686-697. PubMed ID: 28379672
[TBL] [Abstract][Full Text] [Related]
12. Vas deferens invasion: A neglected issue in the sampling of radical prostatectomy materials.
Yigit N; Karslioglu Y; Kurt B
Can Urol Assoc J; 2014 Jul; 8(7-8):E554-7. PubMed ID: 25210563
[TBL] [Abstract][Full Text] [Related]
13. Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesicle invasion (pT3b) without adjuvant therapy.
Forgues A; Rozet F; Audenet F; Ouzzane A; Sanchez-Salas R; Barret E; Galiano M; Prapotnich D; Cathelineau X
World J Urol; 2014 Apr; 32(2):519-24. PubMed ID: 23881352
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of genomic integrity after DNA double strand breaks in the human prostate and seminal vesicle epithelium: the best and the worst.
Jäämaa S; Laiho M
Mol Oncol; 2012 Oct; 6(5):473-83. PubMed ID: 22762987
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomic analysis of proteins involved in the tumorigenic process of seminal vesicle carcinoma in transgenic mice.
Chang WC; Chou CK; Tsou CC; Li SH; Chen CH; Zhuo YX; Hsu WL; Chen CH
Int J Proteomics; 2010; 2010():726968. PubMed ID: 22084680
[TBL] [Abstract][Full Text] [Related]
16. A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.
Pierorazio PM; Ross AE; Schaeffer EM; Epstein JI; Han M; Walsh PC; Partin AW
J Urol; 2011 May; 185(5):1691-7. PubMed ID: 21419448
[TBL] [Abstract][Full Text] [Related]
17. Seminal vesicle invasion in radical prostatectomies: which is the most common route of invasion?
Billis A; Teixeira DA; Stelini RF; Quintal MM; Guimarães MS; Ferreira U
Int Urol Nephrol; 2007; 39(4):1097-102. PubMed ID: 17431809
[TBL] [Abstract][Full Text] [Related]
18. Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significance.
Miyai K; Kristiansen A; Egevad L; Pina-Oviedo S; Divatia MK; Shen SS; Miles BJ; Ayala AG; Park YW; Ro JY
Hum Pathol; 2014 Sep; 45(9):1805-12. PubMed ID: 24993314
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
